WGRX
Wellgistics Health, Inc.
3.08
1 x 2.15
2 x 3.95
bid
ask
+
0.01
0.33%
10:13 AM
timesize
| Ytd | -84.60% | |
| 1y | -93.25% |
3.03
day range
3.08
2.81
52 week range
97.50
| Open | 3.08 | Prev Close | 3.07 | Low | 3.03 | High | 3.08 | Mkt Cap | 7.74M |
| Vol | 2.54K | Avg Vol | 757.06K | EPS | -44.00 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-23 | 50-d Avg | 4.53 | 200-d Avg | 18.56 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 1.56M | ||
| Revenues (USD) | 1.56M | ||
| Cost of Revenue | 1.39M | ||
| Gross Profit | 170.22K | ||
| Operating Expenses | 6.19M | ||
| Selling, General and Administrative Expense | 5.83M | ||
| Operating Income | -6.02M | ||
| Interest Expense | 2.07M | ||
| Net Income | -7.74M | ||
| Net Income Common Stock | -7.74M | ||
| Net Income Common Stock (USD) | -7.74M | ||
| Consolidated Income | -7.74M | ||
| Earnings per Basic Share | -3.50 | ||
| Earnings per Basic Share (USD) | -3.50 | ||
| Earnings per Diluted Share | -3.50 | ||
| Earning Before Interest & Taxes (EBIT) | -5.67M | ||
| Earning Before Interest & Taxes (USD) | -5.67M | ||
| Weighted Average Shares | 2.09M | ||
| Weighted Average Shares Diluted | 2.09M | ||
| Balance Sheet | |||
| Cash and Equivalents | 136.74K | ||
| Cash and Equivalents (USD) | 136.74K | ||
| Trade and Non-Trade Receivables | 996.35K | ||
| Current Assets | 2.76M | ||
| Property, Plant & Equipment Net | 1.05M | ||
| Total Assets | 30.13M | ||
| Debt Current | 15.74M | ||
| Total Debt | 28.73M | ||
| Current Liabilities | 32.20M | ||
| Debt Non-Current | 12.99M | ||
| Total Liabilities | 45.19M | ||
| Accumulated Retained Earnings (Deficit) | -118.77M | ||
| Shareholders Equity | -15.06M | ||
| Shareholders Equity (USD) | -15.06M | ||
| Assets Non-Current | 27.37M | ||
| Total Debt (USD) | 28.73M | ||
| Goodwill and Intangible Assets | 26.24M | ||
| Inventory | 1.71M | ||
| Liabilities Non-Current | 12.99M | ||
| Trade and Non-Trade Payables | 12.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 356.82K | ||
| Net Cash Flow from Financing | 3.63M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 9.16K | ||
| Capital Expenditure | -205.10K | ||
| Issuance (Repayment) of Debt Securities | 3.63M | ||
| Net Cash Flow from Investing | -205.10K | ||
| Net Cash Flow from Operations | -3.41M | ||
| Share Based Compensation | 1.36M | ||